[瘤治疗中的体抗体库技术:一篇评论]
Xiaoyang Chen1, Ruiheng An1, Ju Huang1
1Innovation Center of Molecular Diagnostics, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Sheng wu gong cheng xue bao = Chinese journal of biotechnology
|October 8, 2023
概括
体抗体库技术 (PALT) 为开发单克隆抗体提供了一种快速和多功能方法. 这种技术对于推进瘤治疗至关重要,因为它能够有效选瘤标记物和抗体药物制备.
科学领域:
- 生物技术和免疫学 生物技术和免疫学
- 瘤学 治疗学 治疗学
背景情况:
- 瘤对健康构成重大风险,目前的治疗方法包括手术,化疗,向治疗和免疫治疗.
- 单克隆抗体在癌症治疗中非常重要,因为它们的有效性和低毒性.
结论:
- 体抗体库技术代表了用于癌症治疗的单克隆抗体制备的重大进步.
- 它在查瘤标志物和开发抗体药物的应用突出了其在改善患者乳腺癌,胃癌,肺癌和肝癌的结果方面的潜力.
更多相关视频
12:55Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
Published on: January 17, 2015
18.6K
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
7.8K
相关概念视频
01:27Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
01:31Hybridoma Technology
14.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K